Dana Investment Advisors, Inc. Corcept Therapeutics Inc Transaction History

Dana Investment Advisors, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 15, 2019	SELL	$10.03 - $15.71 $1.09 Million - $1.71 Million	-108,623 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$11.29 - $17.19 $325,603 - $495,759	-28,840 Reduced 20.98%	108,623 $1.45 Million
Q3 2018 Nov 14, 2018	BUY	$12.27 - $15.65 $197,019 - $251,292	16,057 Added 13.23%	137,463 $1.93 Million
Q2 2018 Aug 01, 2018	SELL	$15.3 - $19.69 $22,368 - $28,786	-1,462 Reduced 1.19%	121,406 $0
Q1 2018 May 15, 2018	BUY	$14.59 - $25.5 $1.79 Million - $3.13 Million	122,868 New	122,868 $2.02 Million

361

86.6M

1.12M

667K

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $7.28B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

Get notified when there are updates to the investment portfolio of Dana Investment Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Dana Investment Advisors, Inc. with notifications on news.